Antipodes Partners’s Globant GLOB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9M Buy
651,466
+277,446
+74% +$11.1M 0.35% 56
2026
Q1
$17.2M Buy
374,020
+54,118
+17% +$2.99M 0.33% 52
2025
Q4
$20.9M Buy
+319,902
New +$20.1M 0.44% 50
2024
Q3
Sell
-1,577
Closed -$281K 93
2024
Q2
$281K Buy
1,577
+588
+59% +$104K 0.01% 51
2024
Q1
$200K Buy
989
+17
+2% +$3.82K 0.01% 48
2023
Q4
$231K Sell
972
-327
-25% -$66.8K 0.01% 49
2023
Q3
$257K Sell
1,299
-9
-0.7% -$1.69K 0.01% 48
2023
Q2
$235K Buy
+1,308
New +$215K 0.01% 41

Other funds holding GLOB

Antipodes Partners's GLOB Position: Q2 2026 in Review

Antipodes Partners increased its Globant (GLOB) stake by 74% in Q2 2026, buying an estimated $11.1M and bringing the position to 651,466 shares worth $18.9M. The position accounts for 0.35% of the portfolio, ranked #56.

Antipodes Partners first reported a position in GLOB in Q2 2023 and has held it in 8 quarters since. The position peaked at $20.9M in Q4 2025. 290 funds tracked by Wall St. Rank hold GLOB as of Q2 2026.

  • Antipodes Partners held 651,466 shares of Globant worth $18.9M as of Q2 2026.
  • Antipodes Partners bought 277,446 Globant shares in Q2 2026, an estimated $11.1M.
  • Globant made up 0.35% of Antipodes Partners's portfolio in Q2 2026, its #56 holding.
  • Antipodes Partners first reported a position in Globant in Q2 2023 and has held it in 8 quarters since.
  • Antipodes Partners's Globant position peaked at $20.9M in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Globant as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.